Xarelto Bleeding Lawsuit Filings Transferred And Consolidated By JPML Under U.S. District Judge Eldon Fallon

April 29, 2016 – – BloodThinnerHelp.com reports on the transfer and consolidation of all federally-filed Xarelto related lawsuits by the U.S. Judicial Panel on Multidistrict Litigation. The cases are able to be filed, forming MDL number 2592, due to the fact that they were filed against the same defendants (Bayer and Janssen) and that they contain strikingly similar plaintiff allegations.

The complaints were transferred to a single court in Eastern Louisiana and are now being overseen by the Honorable U.S. District Judge Eldon E. Fallon. The consolidation was issued on December 12, 2015, generating the transfer of these federal cases, and helping to “fast track” the litigation process by avoiding duplicative discovery or different rulings from multiple judges. It will also help to conserve resources for everyone involved.

In just five year’s time, Xarelto lawsuits have grown to number more than 3,400, and have been consolidated to form two major groupings. Lawsuits consolidated in the MDL number over 2,800 and are expected to continue to rise. In addition, these lawsuits are joined by more than 620 other cases which were consolidated to form a mass tort program by the Court of Common Pleas in Philadelphia, Pennsylvania. Plaintiffs involved in these lawsuits synonymously allege that use of new-generation blood-thinning drug Xarelto places users at increased risk for the development of sudden bleeding events, some of which can be life-threatening and prove fatal.

The MDL consolidation decision came in response to a request from a group of plaintiffs submitted in October 2015. The request asked that the JPML centralize the cases to help litigation run more smoothly and efficiently. Initially, plaintiffs asked that the involved cases be centralized in the Southern District of Illinois. The defendants contested this request, however, arguing that the cases should be centralized in New Jersey, where their headquarters were located. Defendant Janssen Pharmaceuticals is a division of corporate giant Johnson & Johnson.

After a hearing session which was held on December 4, 2015, the JPML noted, “In our judgement, the considerable growth in the litigation over the past few months demonstrates that informal coordination is not practical.” Additionally, they stated that they had determined the lawsuits would be overseen by the Honorable Judge Eldon Fallon, and explained, “Judge Eldon E. Fallon, who presides over three potential tag-along (Xarelto) actions, is an experienced transferee judge with the willingness and ability to manage this litigation efficiently. He is well-versed in multidistrict litigation, and we are confident he will steer this matter on a prudent course.”

As the plaintiffs involved in Xarelto lawsuits anxiously await trial dates, many anticipate that filing numbers will continue to steadily grow. At this time, Attorney Joseph Osborne is working to help other patients who have used Xarelto and who feel that the blood thinner has negatively affected their health. He wants to help ensure that all affected patients are provided with an opportunity to fully explore their legal rights, as they may be entitled to significant compensation attained through legal action. To assist those who wish to investigate their options further, Attorney Osborne is now offering complimentary legal consultations to affected parties.

To request further Xarelto lawsuit information, or to ask questions, please contact Joseph Osborne, Esq. by calling (866) 425-8902.

###

Contact BloodThinnerHelp.com:

Joseph Osborne
866-425-8902
Mizner Park
433 Plaza Real Blvd., Ste. 271
Boca Raton, FL 33432

ReleaseID: 60009685